NETRF named Michael German, MD as the NETRF Petersen Investigator for his project entitled, “Treating Neuroendocrine Tumors via Synthetic Lethality” The objective his research is to analyze how the UPR-MEN1-MAPK pathways interact to control neuroendocrine cell survival and death, and to evaluate synthetic lethal interactions in a patient-derived xenograft tumor model of pancreatic neuroendocrine tumors.
Lower gastrointestinal neuroendocrine neoplasms associated with hereditary cancer syndromes: a case series.
Familial cancer
Complicated Case Presentation: Management of Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Pancreas
Radioembolization with 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: final report of a prospective pilot study.
Journal of gastrointestinal oncology